Drug Database
Back to search

United States· US:13517-100_11c83c92-145b-486a-90f3-d759c358d091

Diazoxide

A diazoxide product containing diazoxide, registered in United States by e5 Pharma, LLC. The same ATC class is registered in 5 of our 19 countries.

ATC C02DA01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDiazoxideATCC02DA01REGISTER NO.US:13517-100_11c83c92…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diazoxideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diazoxide is registered in 5 of 19 countries.

Countries holding a registration under ATC C02DA01 (diazoxide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose
Search diazoxide products by name

Diazoxide · ATC C02DA01

5 / 19 countries

  • Finlandprice
  • Germany
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIAZOXIDE
Manufacturer
e5 Pharma, LLC
Country
United States (US)
ATC code
C02DA01
ATC class
Diazoxide
Defined daily dose
0.3 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1351710030
    1 BOTTLE, DROPPER in 1 CARTON (13517-100-30) / 30 mL in 1 BOTTLE, DROPPER
  • ndc11
    13517-100-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for diazoxide.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check diazoxide against other medicinesHow interaction checks work

Diazoxide · interactions on record

248 records

  • 1 severe
  • 243 moderate
  • 4 minor

Most severe, free to view

  • TizanidineM03BX02severe
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diazoxide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diazoxide products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Proglicem
  • France · Proglicem
  • United Kingdom (Northern Ireland) · Eudemine
  • Italy · Proglicem
  • Netherlands · Proglicem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4b9229e-c10b-4a0a-9bf5-b43612bf459e
GET /v1/drugs/b4b9229e-c10b-4a0a-9bf5-b43612bf459e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "DIAZOXIDE",
  "productndc": "13517-100",
  "dosage_form": "SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA211050",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about diazoxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console